CompletedPhase 2NCT02592798
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
Studying Non-genetic systemic disease with glomerulopathy as a major feature
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bristol-Myers Squibb
- Principal Investigator
- Bristol Myers SquibbBristol-Myers Squibb
- Intervention
- Abatacept(drug)
- Enrollment
- 36 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2016 – 2020
Study locations (27)
- The University Of Alabama At Birmingham, Birmingham, Alabama, United States
- University of Alabama-Birmingham-Parent Account, Birmingham, Alabama, United States
- Los Angeles Biomedical Research Institute, Torrance, California, United States
- University Of Colorado Denver, Aurora, Colorado, United States
- Children's National Health System, Washington D.C., District of Columbia, United States
- University Of Miami Miller School Of Medicine, Miami, Florida, United States
- Nemours Childrens Hospital, Orlando, Florida, United States
- Emory University, Atlanta, Georgia, United States
- Loyola University Medical Center, Maywood, Illinois, United States
- NIH Clinical Center - NIDDK, Bethesda, Maryland, United States
- Boston Childrens Hospital, Boston, Massachusetts, United States
- Brigham And Women'S Hosp Inc., Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Childrens Mercy Hospital, Kansas City, Missouri, United States
- +12 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02592798 on ClinicalTrials.govOther trials for Non-genetic systemic disease with glomerulopathy as a major feature
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07271186Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney DiseaseRegeneron Pharmaceuticals
- RECRUITINGNANCT06622915Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic SyndromeSohag University
- RECRUITINGPHASE3NCT05914155Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic SyndromeShoichi Maruyama MD PhD
See all trials for Non-genetic systemic disease with glomerulopathy as a major feature →